Target Name: ZNF30
NCBI ID: G90075
Review Report on ZNF30 Target / Biomarker Content of Review Report on ZNF30 Target / Biomarker
ZNF30
Other Name(s): zinc finger protein 30 | Zinc finger protein 30, transcript variant 1 | zinc finger protein 30 (KOX 28) | KOX28 | zinc finger protein KOX28 | ZNF30 variant 1 | Zinc finger protein 30 (KOX 28) | Zinc finger protein 30 | Zinc finger protein KOX28 | Zinc finger protein 30 (isoform a) | ZNF30_HUMAN

ZNF30: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. One of the ZFPs, ZNF30, has been identified as a potential drug target and biomarker. In this article, we will explore the biology of ZNF30, its potential as a drug target, and its potential as a biomarker for various diseases.

Biochemistry and Structure

ZNF30 is a 21 kDa protein that contains a N-terminal zinc finger domain, a central 灏?-sheet, and a C-terminal T-loop. The N-terminal zinc finger domain consists of a single zinc finger that consists of two parallel strands of amino acids. The central 灏?-sheet is composed of three parallel strands of amino acids that form a灏?-灏? sandwich. The C-terminal T-loop consists of a single loop of amino acids that is involved in the regulation of zinc finger protein activity.

Function

ZNF30 is involved in various cellular processes, including cell growth, differentiation, and inflammation. It is a key regulator of cell proliferation and has been shown to play a role in the regulation of T-cell development and function. ZNF30 has also been shown to be involved in the regulation of cell migration and the maintenance of stem cell self-renewal. In addition, ZNF30 has been shown to play a role in the regulation of gene expression and has been shown to interact with various transcription factors, including NF-kappa-B and AP-1.

Drug Target

ZNF30 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of the reasons for its potential as a drug target is its high degree of sensitivity to small molecules, which makes it an attractive target for drug development. In addition, ZNF30 has been shown to play a role in various signaling pathways, including the T-cell receptor signaling pathway, which makes it an attractive target for inhibitors of this pathway.

Biomarker

ZNF30 has also been identified as a potential biomarker for various diseases. For example, ZNF30 has been shown to be involved in the regulation of cancer cell growth and has been shown to play a role in the development of various types of cancer. In addition, ZNF30 has been shown to be involved in the regulation of autoimmune diseases, including rheumatoid arthritis and multiple sclerosis.

Conclusion

In conclusion, ZNF30 is a protein that has the potential to be a drug target and biomarker. Its unique structure and its involvement in various cellular processes make it an attractive target for drug development. Additionally, its potential as a biomarker for various diseases makes it an attractive target for diagnostic studies. Further research is needed to fully understand the biology of ZNF30 and its potential as a drug target and biomarker.

Protein Name: Zinc Finger Protein 30

Functions: May be involved in transcriptional regulation

The "ZNF30 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF30 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443